Committee Testimony and Witness Signup
HB0417 - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Health 2/10/2026 2:30:00 PM
As of: 3/26/2026 4:58:23 AM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Delegate Pippy, Delegate Pippy | FAV |
In Person - Oral Testimony |
HLT | |
| Mortoro, Lynn | FAV | HB0417 February 10,2026 Public Health.pdf | HLT | |
| Tibbals, Trudy | FAV | No Testimony | HLT | |
| Higdon, Thomas | UNF | MASDP Testimony (written)_HB417_Medetomidine and X | HLT | |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - 2026 HB 417 FAV - Medetomidine and Xyla | HLT |
| Vetter, Drew | FAV | HB0417_FAV_MedChi_PH - Medetomidine and Xylazine C | HLT | |
| Bauer, Danielle | Maryland Veterinary Medical Association | UNF | MDVMA UNF | HLT |
Validation
Please fix the following:
MyMGA
Accessibility Tools